France Softgel Capsule Market Research Report By Type (Gelatin Type, Non-Animal Type) and By Application (Vitamins, Supplement, Nutrition)- Forecast to 2035

France Softgel Capsule Market Overview

As per MRFR analysis, the France Softgel Capsule Market Size was estimated at 281.25 (USD Million) in 2023. The France Softgel Capsule Market Industry is expected to grow from 300(USD Million) in 2024 to 827 (USD Million) by 2035. The France Softgel Capsule Market CAGR (growth rate) is expected to be around 9.657% during the forecast period (2025 - 2035).

Key France Softgel Capsule Market Trends Highlighted

The France Softgel Capsule Market is undergoing substantial trends that are influenced by a variety of factors. The demand for softgel capsules has been bolstered by the growing trend in France toward dietary supplements and nutraceuticals. This increase is associated with the French populace's increasing awareness of health issues, which underscores the importance of wellness solutions and preventive healthcare. Furthermore, the fast-paced lifestyle of consumers has resulted in a preference for convenient dosage forms, which makes softgel capsules an appealing alternative due to their high bioavailability and ease of ingestion. The France Softgel Capsule Market presents significant opportunities. 

The increasing demand for plant-based and vegan softgel formulations is indicative of the evolving consumer preferences for environmentally favorable and natural products. Innovative formulations that integrate natural ingredients are encouraged to be explored by manufacturers in order to cater to the environmentally conscious segment of the market. Additionally, the softgel capsule sector in France is significantly influenced by the aging population, as older individuals frequently seek supplements to improve their cognitive function, joint health, and overall well-being. 

French consumers are increasingly prioritizing transparency and sustainability in the sourcing and manufacturing of products, as evidenced by recent trends. They exhibit a preference for softgel capsules that prioritize ethical standards, safety, and quality. Companies are increasingly emphasizing sustainable packaging solutions and clean-label formulations in accordance with the French regulatory framework, which prioritizes environmental sustainability and consumer protection.Therefore, the France Softgel Capsule Market is undergoing a rapid transformation, which is indicative of the broader change in consumer behavior toward transparency, sustainability, and health.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

France Softgel Capsule Market Drivers

Increasing Demand for Dietary Supplements

The France Softgel Capsule Market Industry is witnessing a significant surge in demand for dietary supplements due to increasing health consciousness among the populace. According to the Ministry of Health in France, nearly 42% of adults regularly consume dietary supplements, indicating a robust interest in health and wellness products. This trend is partly driven by the aging population in France, with statistics showing that the proportion of individuals aged 65 and over is expected to reach 20% of the total population by 2030.

Industry leaders like Arkopharma and Lactalis Ingredients have noted this growing demand in their reports, showing an increased focus on softgel formulations that appeal to health-oriented consumers. The rising awareness around nutrition and preventive healthcare further bolsters growth in the France Softgel Capsule Market Industry, creating a favorable environment for new product developments and innovations.

Advancements in Softgel Technology

The France Softgel Capsule Market Industry is benefitting from advancements in softgel technology, which have led to improved bioavailability of active ingredients. Leading companies like Capsugel in France have been involved in substantial Research and Development (R&D) initiatives focused on creating innovative softgel formulations that enhance the absorption rates of vitamins and minerals. 

The technological enhancements have reportedly allowed manufacturers to expand their product offerings, with estimates suggesting that bioenhanced softgels could see a 30% higher absorption rate compared to traditional tablets or powders.This advancement resonates particularly with health-conscious consumers seeking optimal nutrient delivery, thereby driving market growth.

Increased Prevalence of Chronic Diseases

The rising incidence of chronic diseases, such as cardiovascular diseases and diabetes in France is a significant driver for the France Softgel Capsule Market Industry. The French National Institute of Health and Medical Research indicates that nearly 14 million people in France suffer from chronic ailments, leading to increased healthcare costs and a greater focus on preventive measures. As a result, there is a heightened consumer shift towards dietary and nutritional supplements that may aid in managing health conditions.

This growing prevalence motivates pharmaceutical and dietary supplement companies to invest in softgel products that can offer therapeutic benefits, thus facilitating the substantial market growth.

Regulatory Support for Nutraceuticals and Supplements

Supportive regulatory frameworks around nutraceuticals and dietary supplements in France are fostering growth in the France Softgel Capsule Market Industry. The French Food Safety Agency has streamlined processes for product approvals and safety evaluations, making it easier for companies to enter the market. Reports suggest that the regulatory environment has been moving towards standardizing supplement formulations, leading to increased consumer trust in the quality of products available. 

This favorable policy environment allows for more innovation and investment in the softgel segment, aiding manufacturers in faster market penetration of new softgel products tailored to meet specific health needs.

France Softgel Capsule Market Segment Insights

Softgel Capsule Market Type Insights

The France Softgel Capsule Market is prominently characterized by its diverse Type segment, which triumphs in providing various formulations suited to a wide range of dietary and medicinal preferences. The Gelatin Type segment, a stalwart within the market, is majorly derived from animal sources, primarily from porcine and bovine origins. It is well-regarded for its excellent bioavailability and compatibility in delivering medicinal compounds effectively. This segment's prominence is strategic, as it caters to the traditional expectations of consumers who are accustomed to products derived from natural sources. In contrast, the Non-Animal Type, which includes vegetarian and vegan softgel capsules, has gained significant traction among health-conscious consumers, reflecting an increasing trend toward plant-based alternatives in dietary supplements. 

This growing consumer awareness about animal welfare and dietary restrictions has propelled the demand for Non-Animal Type, highlighting its importance in capturing a segment of the market that is often overlooked. Furthermore, as consumers in France become more conscientious about their food sources and health impacts, this sub-segment is increasingly recognized as critical in addressing niche markets, including those seeking lactose-free or gluten-free options. The market in France is bolstered by the government's encouragement of healthy living and the development of alternative medicine, which supports both Gelatin and Non-Animal Type segments in competing effectively. The Gelatin Type continues to be widely used because of its established reputation. 

At the same time, the Non-Animal Type is positioned to disrupt traditional norms by offering innovative solutions that align with modern dietary preferences. As the market progresses, both segments are expected to capitalize on the rising health trends, with consumers increasingly seeking personalized and flexible health solutions. This trend dovetails with France's robust regulatory framework that emphasizes consumer safety and quality, which is essential in fostering industry growth. 

Each segment presents unique opportunities; the Gelatin Type offers reliability and effectiveness in product delivery, while the Non-Animal Type promises innovation and inclusivity in dietary choices. Together, these segments are set to drive the France Softgel Capsule Market towards new horizons, meeting the evolving demands of consumers within the region while contributing significantly to market dynamics.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Softgel Capsule Market Application Insights

The Application segment of the France Softgel Capsule Market comprises key areas such as Vitamins, Supplements, and Nutrition. This segment is increasingly favored due to the rising health consciousness among consumers in France, who are seeking convenient and effective ways to meet their dietary needs. Softgel capsules are known for their ease of consumption and better bioavailability, making them a preferred choice for dietary formulations. Vitamins hold a significant share within this segment, driven by an aging population focused on preventive healthcare and wellness.Additionally, the Supplements category often includes herbal and nutritional products that cater to various health concerns, gaining traction in the health and wellness market. 

The Nutrition aspect emphasizes the importance of balanced diets and fortified foods, aligning with initiatives by health authorities in France to promote nutritional awareness. Challenges faced in this segment include regulatory compliance and consumer skepticism about efficacy, but opportunities exist in innovative product development and increasing demand for plant-based and organic options.Overall, the France Softgel Capsule Market segmentation highlights a dynamic landscape driven by changing consumer preferences towards health-related products.

France Softgel Capsule Market Key Players and Competitive Insights

The France Softgel Capsule Market is characterized by a competitive landscape that is influenced by several key players operating in the region. This market is driven by the growing demand for dietary supplements and pharmaceuticals, which has led to an increase in the production and consumption of softgel capsules. The competitive insights reveal a focus on innovation, quality control, and customer satisfaction among manufacturers. The market is seeing an influx of both established companies and new entrants who are capitalizing on the rising health consciousness among consumers. Additionally, the market is marked by strategic collaborations, product launches, and an emphasis on research and development to create specialized softgel formulations that cater to various health needs, thus ensuring sustained growth and competitiveness.

Ginkgo BioWorks has carved a niche within the France Softgel Capsule Market through its strong emphasis on biotechnology and synthetic biology. The company leverages its advanced capabilities in genetic engineering to develop products that meet the specific demands of the health and nutrition sectors. Known for its innovative approach, Ginkgo BioWorks focuses on creating custom organisms for a variety of applications, including dietary supplements that are gaining traction in France. The company's strengths lie in its strong R&D capabilities, strategic partnerships within the biotech community, and a commitment to sustainability. This positions Ginkgo BioWorks as a formidable player in the market as it adapts to consumer preferences and regulatory requirements within France.

Lonza holds a significant presence in the France Softgel Capsule Market by offering a broad range of products and services that cater to the pharmaceutical and nutraceutical sectors. The company is recognized for its high-quality softgel manufacturing capabilities, which include expertise in formulation development, encapsulation technologies, and clinical trials. Lonza's strengths include its extensive experience, robust supply chain, and advanced production facilities located within France, which enhance its operational efficiency and responsiveness to market demands. 

The company has engaged in strategic mergers and acquisitions to expand its product portfolio and strengthen its competitive edge, allowing for greater innovation and improved market outreach. Lonza also offers tailored solutions to meet customer needs, making it a trusted partner in the development of softgel products in the region.

Key Companies in the France Softgel Capsule Market Include:

• Ginkgo BioWorks


• Lonza


• BASF


• Gelita


• ABH Pharma


• Colorcon


• Nutraceutical Corporation


• Capsugel


• Rgroup


• Kavita


• Thorne Research


• Softgel Technologies


• Pharmalink


• Ashland


• Procaps Group

France Softgel Capsule Market Industry Developments

In recent months, the France Softgel Capsule Market has experienced various notable developments. Companies like Ginkgo BioWorks and Lonza have focused on expanding their production capabilities to meet the growing consumer demand for dietary supplements, particularly in the nutraceutical sector. The market showed growth valuations, positively impacting firms such as BASF and Gelita as they invest in innovative gelatin products that cater to health-conscious consumers. 

In July 2023, ABH Pharma announced a significant partnership with Pharmalink aimed at enhancing drug delivery systems, signaling continued collaboration within the sector. The acquisitions space also saw activity when Capsugel completed its merger with Rgroup in March 2023, strengthening its foothold in France's softgel market.

Furthermore, Thorne Research and Softgel Technologies reported increased research initiatives to improve softgel formulations, aiming to capitalize on rising health and wellness trends. France's emphasis on health regulations has spurred demand for high-quality softgel products, contributing to the growth trajectory of firms like Nutraceutical Corporation and Ashland in this market. 

Overall, the Softgel Capsule Market in France is undergoing notable evolution, driven by partnerships, mergers, and a strong focus on innovation and quality enhancement.

France Softgel Capsule Market Segmentation Insights

Softgel Capsule Market Type Outlook

• Gelatin Type


• Non-Animal Type

Softgel Capsule Market Application Outlook

• Vitamins


• Supplement


• Nutrition

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	281.25(USD Million)
MARKET SIZE 2024	300.0(USD Million)
MARKET SIZE 2035	827.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	9.657% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Ginkgo BioWorks, Lonza, BASF, Gelita, ABH Pharma, Colorcon, Nutraceutical Corporation, Capsugel, Rgroup, Kavita, Thorne Research, Softgel Technologies, Pharmalink, Ashland, Procaps Group
SEGMENTS COVERED	Type, Application
KEY MARKET OPPORTUNITIES	Rising demand for dietary supplements, Growing interest in personalized nutrition, Expansion of online distribution channels, Increasing investment in R&D, Rising health awareness among consumers
KEY MARKET DYNAMICS	increasing demand for dietary supplements, rising aging population, growth of healthcare sector, advancements in capsule technology, preference for liquid formulations
COUNTRIES COVERED	France